Tessa Werner

Tessa Werner

Auto-generated profile, based on publicly available information

Tessa Werner

Institute for Molecular Bioscience, The University of Queensland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Stem Cell Reports
Verified
Journal Article
Open access
IMIngra Mannhardt
Ingra Mannhardt
KBKaja Breckwoldt
Kaja Breckwoldt
DLDavid Letuffe-Brenière
David Letuffe-Brenière
SSSebastian Schaaf
Sebastian Schaaf
HSHerbert Schulz
Herbert Schulz
AHArne Hansen
Arne Hansen
Analyzing contractile force, the most important and best understood function of cardiomyocytes in vivo is not established in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM). This study describes the generation of 3D, strip-format, force-generating engineered heart tissues (EHT) from hiPSC-CM and their physiological and pharmacological properties. CM were differentiated from hiPSC by a growth factor-based three-stage protocol. EHTs were generated and analyzed histologically and functionally. HiPSC-CM in EHTs showed well-developed sarcomeric organization and alignment, and frequent mitochondria. Systematic contractility analysis (26 concentration-response curves) reveals that EHTs replicated canonical response to physiological and pharmacological regulators of inotropy, membrane- and calcium-clock mediators of pacemaking, modulators of ion-channel currents, and proarrhythmic compounds with unprecedented precision. The analysis demonstrates a high degree of similarity between hiPSC-CM in EHT format and native human heart tissue, indicating that human EHTs are useful for preclinical drug testing and disease modeling.

11 May 2017 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
KBKaja Breckwoldt
Kaja Breckwoldt
DLDavid Letuffe-Brenière
David Letuffe-Brenière
IMIngra Mannhardt
Ingra Mannhardt
TSThomas Schulze
Thomas Schulze
BUBärbel Ulmer
Bärbel Ulmer
AHArne Hansen
Arne Hansen

13 September 2016 in Circulation
Verified
Journal Article
Closed access
PDF file
JBJavier Barallobre-Barreiro
Javier Barallobre-Barreiro
SGShashi K. Gupta
Shashi K. Gupta
AZAnna Zoccarato
Anna Zoccarato
RKRika Kitazume-Taneike
Rika Kitazume-Taneike
MFMarika Fava
Marika Fava
MMManuel Mayr
Manuel Mayr
Background: Myocardial fibrosis is a feature of many cardiac diseases. We used proteomics to profile glycoproteins in the human cardiac extracellular matrix (ECM). Methods: Atrial specimens were analyzed by mass spectrometry after extraction of ECM proteins and enrichment for glycoproteins or glycopeptides. Results: ECM-related glycoproteins were identified in left and right atrial appendages from the same patients. Several known glycosylation sites were confirmed. In addition, putative and novel glycosylation sites were detected. On enrichment for glycoproteins, peptides of the small leucine-rich proteoglycan decorin were identified consistently in the flowthrough. Of all ECM proteins identified, decorin was found to be the most fragmented. Within its protein core, 18 different cleavage sites were identified. In contrast, less cleavage was observed for biglycan, the most closely related proteoglycan. Decorin processing differed between human ventricles and atria and was altered in disease. The C-terminus of decorin, important for the interaction with connective tissue growth factor, was detected predominantly in ventricles in comparison with atria. In contrast, atrial appendages from patients in persistent atrial fibrillation had greater levels of full-length decorin but also harbored a cleavage site that was not found in atrial appendages from patients in sinus rhythm. This cleavage site preceded the N-terminal domain of decorin that controls muscle growth by altering the binding capacity for myostatin. Myostatin expression was decreased in atrial appendages of patients with persistent atrial fibrillation and hearts of decorin null mice. A synthetic peptide corresponding to this decorin region dose-dependently inhibited the response to myostatin in cardiomyocytes and in perfused mouse hearts. Conclusions: This proteomics study is the first to analyze the human cardiac ECM. Novel processed forms of decorin protein core, uncovered in human atrial appendages, can regulate the local bioavailability of antihypertrophic and profibrotic growth factors.

1 February 2016 in Molecular Metabolism
Verified
Journal Article
Open access
MSMichaela Schäfer
Michaela Schäfer
COChristian U. Oeing
Christian U. Oeing
MRMaria Rohm
Maria Rohm
EBEzgi Baysal-Temel
Ezgi Baysal-Temel
LLLorenz H. Lehmann
Lorenz H. Lehmann
SHStephan Herzig
Stephan Herzig
Cancer cachexia affects the majority of tumor patients and significantly contributes to high mortality rates in these subjects. Despite its clinical importance, the identity of tumor-borne signals and their impact on specific peripheral organ systems, particularly the heart, remain mostly unknown. By combining differential colon cancer cell secretome profiling with large-scale cardiomyocyte phenotyping, we identified a signature panel of seven "cachexokines", including Bridging integrator 1, Syntaxin 7, Multiple inositol-polyphosphate phosphatase 1, Glucosidase alpha acid, Chemokine ligand 2, Adamts like 4, and Ataxin-10, which were both sufficient and necessary to trigger cardiac atrophy and aberrant fatty acid metabolism in cardiomyocytes. As a prototypical example, engineered secretion of Ataxin-10 from non-cachexia-inducing cells was sufficient to induce cachexia phenotypes in cardiomyocytes, correlating with elevated Ataxin-10 serum levels in murine and human cancer cachexia models. As Ataxin-10 serum levels were also found to be elevated in human cachectic cancer patients, the identification of Ataxin-10 as part of a cachexokine cocktail now provides a rational approach towards personalized predictive, diagnostic and therapeutic measures in cancer cachexia.

1 April 2015 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
MHMarc N. Hirt
Marc N. Hirt
TWTessa Werner
Tessa Werner
DIDaniela Indenbirken
Daniela Indenbirken
MAMalik Alawi
Malik Alawi
PDPaul Demin
Paul Demin
TEThomas Eschenhagen
Thomas Eschenhagen

17 December 2015 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
JSJustus Stenzig
Justus Stenzig
MHMarc N. Hirt
Marc N. Hirt
ALAlexandra Löser
Alexandra Löser
LBLena M. Bartholdt
Lena M. Bartholdt
JHJan-Tobias Hensel
Jan-Tobias Hensel
TEThomas Eschenhagen
Thomas Eschenhagen